NCT02765191View on ClinicalTrials.gov

MR-Evaluation of Renal Function In Septic Patients

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 7, 2016

Primary Completion Date

May 10, 2021

Study Completion Date

August 10, 2021

Conditions
Sepsis, SevereAcute Kidney InjuryCOVID-19
Interventions
OTHER

Plasma expansion with Ringer's Acetate

7,5 ml/kg mL Ringer's acetate during 5-10 minutes will be administered intravenously

Trial Locations (1)

751 85

Uppsala University Hospital, Uppsala

All Listed Sponsors
lead

Uppsala University

OTHER

NCT02765191 - MR-Evaluation of Renal Function In Septic Patients | Biotech Hunter | Biotech Hunter